Acetaminophen is sometimes given to infants and small
children following shots to prevent fever, a common reaction to vaccinations.
This study examined the effects of acetaminophen on immune response after
initial and booster vaccinations.
Two hundred twenty-six children from 10 different medical
centers were randomly selected to receive three doses every six to eight hours
for 24 hours after immunizations. Just 42 percent of these children experienced
fevers (100.4 degrees F or above), compared to 66 percent of a control group of
233.
When it was time for booster shots, parents were asked to
repeat the process. There was a lower incidence of fever in both groups—36
percent for those who took acetaminophen and 58 percent for those who did not.
Children who received acetaminophen , however, had fewer
antibodies, indicating more susceptibility to disease. In the studied children,
pneumonia, hepatitis B, whooping cough, polio, diphtheria and tetanus
antibodies were fewer following vaccinations and boosters with acetaminophen
use.
Antibodies are proteins in the immune system
(immunoglobulins) that bind to harmful pathogens (viruses) to keep them away
from healthy white blood cells. Without these antibodies, the body’s immune
system is more susceptible to disease.
When vaccines fail to protect against diseases, the health
of the entire community is at stake because viruses are more easily spread.
“This point has implications, especially for Haemophilus
influenzae, for which higher and sustained antibody concentrations are needed
(to reduce transmission),” says Dr. Robert T Chen of the Centers for Disease
Control in Atlanta, “…and for pertussis, the bacterial vaccine-preventable
disease that is least controlled.”
Although they’re not entirely sure why children taking
acetaminophen had fewer antibodies, doctors plan to explore the issue further.
They stress the importance of this information, and advise against unnecessary
acetaminophen use.
“(A)dministration of antipyretic drugs at the time of
vaccination should nevertheless no longer be routinely recommended without
careful weighing of the expected benefits and risks,” wrote lead author Dr.
Roman Pryula of the University of Defense in Hradec Kralove, Czech Republic.
The study appears in this month’s online issue of The
Lancet.
About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site
©2010. Healia / Meredith Corporation
Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.